Trials / Unknown
UnknownNCT04807621
Platelets or Fibrinogen as First-line Treatment for Bleeding During Pedatric Heart Surgery
Platelets or Fibrinogen as First-line Treatment for Bleeding During Pedatric Heart Surgery: a Randomized, Controlled Trial.
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Sahlgrenska University Hospital · Academic / Other
- Sex
- All
- Age
- 12 Months
- Healthy volunteers
- Not accepted
Summary
The study aims to test whether platelet transfusion or fibrinogen concentrate is the most effective treatment of intraoperative bleeding, when performing open heart surgery with cardiopulmonary bypass on children with congenital heart defects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Platelet transfusion | Platelets (10 ml/kg body weight) is transfused. |
| BIOLOGICAL | Fibrinogen concentrate | Fibrinogen concentrate (300 mg/kg body weight) is administered. |
Timeline
- Start date
- 2018-03-14
- Primary completion
- 2022-01-01
- Completion
- 2022-08-01
- First posted
- 2021-03-19
- Last updated
- 2021-03-19
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT04807621. Inclusion in this directory is not an endorsement.